Browse All Treatments

Showing 1856 records.


Page 4 of 186 1 2 3 4 5 6 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
3152.9 monthscolorectal (metastatic)2Immunotherapy, Biologic therapyOspedale Civile di AvezzanoItalySep 2006
Treatment Details: Patients: This phase II study compared two groups of patients. The group receiving the study treatment consisted of 40 people, 26 men and 14 women. The other group, historical co... read more
3252.9 monthsMetastatic colorectal2Immunotherapy, Biologic therapyOspedale Civile di AvezzanoItalySep 2006
Treatment Details: Patients: This phase II study compared two groups of patients. The group receiving the study treatment consisted of 40 people, 26 men and 14 women. The other group, historical co... read more
3351.8 monthsBladder cancer5ChemotherapyCentral Institute of Mental Health Manheim/University of HeidelbergGermanyAug 2005
Treatment Details: Patients: This phase III study involved patients with locally advanced bladder cancer who had previously undergone surgery to treat their cancer. Patients were divided into 2 sep... read more
3451.6 monthsResidual stage III ovarian cancer5ChemotherapyAlbert Einstein College of Medicine United StatesAug 2009
Treatment Details: Patients: This phase 2 study involved 63 women with stage 3 ovarian cancer. The median age was 59, ranging from 34 to 80 years old. Treatment: Patients were treated with chemo... read more
3551.0 monthsNHL5Biologic therapy, Hormone, ChemotherapyMansoura UniversityEgyptNov 2014
Treatment Details: Patients: This study involved HCV-positive diffuse large B-cell lymphoma patients who were divided into two separate treatment groups. Group A consisted of 200 patients with an av... read more
3650.0 monthsIndolent NHL4Biologic therapy, RadiationUniversity of Western Australia, Fremantle HospitalAustraliaSep 2006
Treatment Details: Patients: This phase II study involved 91 indolent non-Hodgkin’s lymphoma patients with a median patient age of 62 years; 60% were male. Treatment: Patients were treated with ... read more
3749.4 monthsResectable metastatic colorectal carcinoma to the liver5SurgeryQueens Hospital CenterUnited StatesMar 2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in ... read more
3849.4 monthsResectable metastatic colorectal carcinoma to the liver5SurgeryQueens Hospital CenterUnited StatesMar 2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in ... read more
3948.7 monthsMucosal melanoma4ChemotherapyPeking University Cancer Hospital & InstituteChinaAug 2013
Treatment Details: Patients: This phase 2 study involved mucosal melanoma patients who were divided into two separate treatment groups. Group A consisted of 63 patients with a median age of 55 year... read more
4048.5 monthsNonmetastatic, hormone-refractory prostate cancer5Biologic therapyUniversity of Pittsburgh School of MedicineUnited StatesNov 2008
Treatment Details: Patients: This phase 3 study involved 941 patients with non-metastatic, hormone-refractory prostate cancer. These men ranged in age from 47 to 93 years of age. The average time f... read more
Page 4 of 186 1 2 3 4 5 6 186